Synthesis and evaluation of novel 1,3,4-thiadiazole-fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDemirci, Asli
dc.contributor.authorKarayel, Kaan Gokce
dc.contributor.authorTatar, Esra
dc.contributor.authorOktem Okullu, Sinem
dc.contributor.authorUnubol, Nihan
dc.contributor.authorTasli, Pakize Neslihan
dc.contributor.authorKocagoz, Zuhtu Tanil
dc.contributor.authorSahin, Fikrettin
dc.contributor.authorKucukguzel, Ilkay
dc.date.accessioned2025-10-16T15:26:14Z
dc.date.issued2018
dc.description.abstract50th International Conference on Medicinal Chemistry (RICT), Rouen, FRANCE, JUL 02-04, 2014
dc.identifier.doi10.3906/kim-1710-35
dc.identifier.otherWOS:000433980300019
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8363
dc.publisherTubitak Scientific \& Technological Research Council Turkey
dc.sourceTURKISH JOURNAL OF CHEMISTRY
dc.subjectFluoroquinolones
dc.subject1
dc.subject3
dc.subject4\\-thiadiazoles
dc.subjectantibacterials
dc.subjecttuberculosis
dc.subjectDNA gyrase
dc.subjectmolecular modeling
dc.subjectcytotoxicity
dc.titleSynthesis and evaluation of novel 1,3,4-thiadiazole-fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents
dc.typeArticle; Proceedings Paper

Dosyalar

Koleksiyonlar

WOS